Acute renal failure (ARF) occurs frequently in hospitalised patients and is
associated with significant morbidity and mortality. Many therapeutic stra
tegies have been undertaken both to prevent acute renal injury and, once AR
F occurs, to improve renal function and reduce mortality. Among the availab
le pharmacological options, no specific therapy has been shown to alter the
course of ARF. This article reviews the efficacy of several strategies in
experimental renal disease and raises the possibility that similar interven
tions might be available to the clinician in the near future for the preven
tion and management of ARF. The prospect of these novel strategies together
with the ever-increasing understanding of the complex pathophysiology of A
RF, offers the promise of effective and more physiological therapeutic inte
rventions in this new millennium.